This Week in Psychedelics - 3.19.21

Cannabis

• White House staffers asked to resign or work remotely after revealing past marijuana use (CNN)

• Wyoming Lawmakers Approve Marijuana Legalization Bill Sponsored By Top GOP Leaders (Marijuana Moment)

• Wisconsin GOP Lawmakers File Bill To Decriminalize Marijuana, While Governor Pushes Full Legalization (Marijuana Moment)

• Nebraska Gov. Ricketts warns: 'If you legalize marijuana, you're going to kill your kids' (USA Today)

• People of Color Made Up 94% of All Pot Arrests in New York in 2020, NYPD Data Reports (MERRY JANE)

• Marijuana Banking Bill Reintroduced In Congress With Broad Bipartisan Support From More Than 100 Lawmakers (Marijuana Moment)

• Big Alcohol and Big Tobacco Coalition Emerges to Shape Legalization in Their Favor (NORML)

• Delaware Lawmakers File Marijuana Legalization Bill Despite Governor’s Ongoing ‘Concerns’ (Marijuana Moment)

• New Mexico Marijuana Legalization Bill Heads To Senate Floor Following Contentious Committee Hearing (Marijuana Moment)

• Colorado Is Trying to Implement 15% THC Cap on High-Potency Cannabis Concentrates (MERRY JANE)

• North Dakota Marijuana Legalization Bill Receives First Senate Committee Hearing Following House Passage (Marijuana Moment)

• Congress and USPS Inadvertently Restrict Consumer Access To Vaporizer Cartridges, Batteries, Etc (NORML)

• New PTSD study finds cannabis safe, but not as effective as assumed (Leafly)

• Pennsylvania: Police Arrested 20,200 Adults for Marijuana Possession During Pandemic (NORML)

• New Evidence Shows CBD Can Help Fight Alzheimer's Disease (MERRY JANE)

• Medical cannabis can reduce essential tremor: turns on overlooked cells in central nervous system (EurekAlert!)

• Cultivating a Single 8th of Weed Creates 41-Pound Carbon Footprint, Study Finds (MERRY JANE)

LSD

• The true story of Michel Foucault's LSD trip that changed history (Salon)

Magic Mushrooms

• COMPASS Pathways Is Trying to Patent Psilocybin for More Mental Health Conditions Than You Can Name (Psymposia)

• Experts chosen to create Oregon’s new system of psilocybin-assisted therapy (OPB)

• Can Magic Mushrooms Heal Us? (The New York Times)

• Revive Therapeutics Announces Successful Research Results for Psilocybin to Treat Traumatic Brain Injury and Filing of International Patent Application (Psilocybin Alpha)

• Can Psilocybin Assisted Psychotherapy Change Attachment Style? (Psychedelic Science Review)

• Shrooms Movie: The Best (And Worst) Movies to Watch on Shrooms (DoubleBlind)

MDMA

• The Effects of MDMA on Emotional Processing (Truffle Report)

DMT

• Pharmadrug Initiates DMT Research Activities via Collaboration with the University of Michigan for Foundational DMT Research Study (Psilocybin Alpha)

5-MeO-DMT

• Former porn star Nacho Vidal to stand trial for death by toad venom (Euro Weekly News)

Ketamine

• First ketamine-assisted psychotherapy Bristol clinic opens (BBC)

• 'How ketamine helped me kick my alcohol addiction' (The Telegraph)

• Having Sex on Ketamine: Getting Physical on a Dissociative (Reality Sandwich)

• On Ketamine and Memories (Truffle Report)

• Ketamine: A Legal, yet Overlooked Psychedelic (Sapiensoup Blog)

PCP

• Rochester mayor lied to public about Daniel Prude case, report finds (New York Post)

Miscellaneous

• D.C. Psychedelics Decriminalization Initiative Officially Takes Effect (Marijuana Moment)

• Sounding the Alarm on Compass’s Interference with Oregon’s Psilocybin Therapy Program (Dr. Bronner)

• Psychedelic drug users tend to have better overall physical health than non-users, study finds (PsyPost)

• Rhode Island Senators File Drug Decriminalization Bill (Marijuana Moment)

• Psychedelic Capitalism and Other Myths: Is the Joke On Us? (Psychedelics Today)

• Capitalism Goes Rogue with Patent Claims on Psychedelics (Chacruna)

• Australian government backs psychedelic drug clinical trials to treat mental illness (The Guardian)

• Why Oneness is Not Incompatible with Identity Politics (Chacruna)

• The Bread That Made an Entire Island Hallucinate (VICE)

• Psychedelic therapy could 'reset' depressed brain (BBC)

• Do Psychedelics Alter the Menstrual Cycle? (DoubleBlind)

• Psychotic- vs. Psychedelic-Induced Hallucinations: A Closer Look (Psychedelic Science Review)

• ‘The ketamine blew my mind’: can psychedelics cure addiction and depression? (The Guardian)

• Fish and Trips: Psychoactive Denizens of the Deep (Truffle Report)

• Why Microdosing is the Lightsaber of Modern-Day Jedis (The Third Wave)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 3.12.21

Cannabis

• Mexican lawmakers advance bill to legalize recreational cannabis (Leafly)

• Hawaii Senate Approves Marijuana Legalization Bill And Separate Decriminalization Expansion Proposal (Marijuana Moment)

• Virginia Governor Considers Speeding Up Legal Marijuana Timeline (Marijuana Moment)

• South Dakota: Legislative Effort to Delay Implementation of Voter-Approved Medical Marijuana Law Fails (NORML)

• Mississippi House kills medical marijuana bill. Senate tries a hail Mary (Mississippi Today)

• Legislation Introduced To No Longer Deny Citizenship Based on Cannabis Consumption (NORML)

• Thai households now allowed to grow six cannabis plants a year (BusinessLIVE)

• New cannabis coalition wants to influence how — not if — weed is legalized (Politico)

• Rhode Island Senate Leaders Unveil Marijuana Legalization Bill As Governor Prepares Competing Plan (Marijuana Moment)

• Lawmakers In Several States Consider Enacting or Expanding Medical Cannabis Access (NORML)

• Nearly 30,000 Californians Just Had Felony Weed Offenses Reduced to Misdemeanors (MERRY JANE)

• Review: Cannabinoids Effective and Well-Tolerated in Patients with Post-Traumatic Stress (NORML)

• Plymouth Massachusetts Introduces a New Medical Research Website for Cannabis (PR Newswire)

• Indoor Weed Farms Are Hotboxing the Planet (Gizmodo)

• Vaping Weed May Actually Be Worse for Your Lungs Than Smoking Cigarettes, Study Says (MERRY JANE)

LSD

• Psychedelics research: Scientists zero in on the ideal dose of LSD to use in psychiatric treatment (PsyPost)

• LSD Brings Your Brain to the Edge of Chaos (VICE)

• When Acid Makes You Feel Like Jesus (DoubleBlind)

Magic Mushrooms

• New York Lawmaker Files Bill To Decriminalize Psilocybin Mushrooms (Marijuana Moment)

• DEA Sued By Doctor Who Wants Permission To Give Psilocybin Mushrooms To Patients (Marijuana Moment)

• Mind Medicine Australia urges TGA to reverse its Interim Decision on scientific and humanitarian grounds (Mind Medicine Australia)

• Psilocybin Therapy Could Help With Obesity (Baystreet)

• How Red Light Holland Is Bringing Psilocybin Truffles Mainstream (Benzinga)

MDMA

• The impact COVID-19 had on MDMA this festival season (Newshub)

DMT

• DMT and Stroke Research (Truffle Report)

Ayahuasca

• Best Ayahuasca Retreats: How to Choose the Right Ayahuasca Retreat For You (DoubleBlind)

5-MeO-DMT

• Three Friends Explore The Obscure And Potent Substance 5-MeO-DMT In This Existentially Intense Film Doc (Forbes)

Iboga

• Ibogaine Treatment for Trauma (PR Newswire)

Novel Psychoactive Substances

• Is 18-MC a Psychedelic Drug? (Psychedelic Science Review)

Ketamine

• Yes, Ketamine Addiction Is a Thing. Here’s What You Need to Know. (DoubleBlind)

• Intravenous ketamine appears safe, efficacious for adolescents with depression (Healio)

• Lower dose of ketamine is as effective as the standard dose to treat pain in adults (News-Medical.net)

• Best Ketamine Clinics and Therapists: What to Look for if You’re Seeking Ketamine Therapy, and How to Find Ketamine Clinics Near You (DoubleBlind)

Miscellaneous

• Investors Are Debating Who Should Own the Future of Psychedelics (VICE)

• The Race to Patent Psychedelics Is Just Getting Started (VICE)

• Vermont Lawmakers Propose Decriminalizing Drugs (Truffle Report)

• Michigan Activists Launch Statewide Campaign to Decriminalize Entheogenic Plants, Fungi (Truffle Report)

• Why mental health researchers are studying psychedelics all wrong (Salon)

• Report finds people use psychedelic drugs to self-medicate for depression, anxiety and trauma (TheJournal.ie)

• Some Thoughts on For-Profit Psychedelic Startups and Companies (Tim Ferriss)

• An open letter to Tim Ferriss about the value of patents in the psychedelic world (LinkedIn)

• How to Penetrate Clubhouse’s Psychedelic Underground (Lucid News)

• California May Ban Most Employers From Drug Testing People Upon Employment (MERRY JANE)

• Lifetime psychedelic use may reduce likelihood of hypertension (Healio)

• Psychedelic Speech: How Drugs Disorganize Normal Communication Patterns (Psychedelic Science Review)

• New Coalition Seeks Federal Psychedelic Research Funds (Truffle Report)

• The Outlaw Chemists Who Deserve a Cut of the Psychedelic Gold Rush (The New Republic)

• Gurus Behaving Badly: Anaïs Nin’s Diary & the Value of Gossip (Chacruna)

• The Pitfalls and Challenges of Psychedelic Medicine (Psychedelic Science Review)

• Psychedelics and Ancient Art: A History of Confirmation Bias (Truffle Report)

• The Shamanic Persona (Maps of the Mind)

• Psychedelic Science Holds Promise for Mainstream Medicine (UNLV)

• Seeking a True Shaman in the Sierra Mazateca (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

Film Review - Psychedelia

A new documentary focusing on the history and science behind psychedelics titled Psychedelia is on the verge of being released soon. Sporting a compact 58-minute run-time, this film clocks in at just under an hour and it provides an easily-digestible, high-level overview of psychedelics for a wide audience, from the uninitiated square all the way to the most seasoned psychonaut.

The film opens with a moving quote that properly sets the tone:

The most beautiful and profound emotion we can experience is the sensation of the mystical. It is the sower of all true science.

-Albert Einstein

The introduction consists of a series of beautiful scenes featuring natural landscapes and voice-overs from people who healed themselves by working with psychedelics. It’s only about a minute long but it’s just enough to give the viewer a glimpse of how transformational these medicines can be when used wisely.

Following the introduction, the documentary launches into the history of psychedelics, from Albert Hofmann’s first intentional acid trip all the way up to the new wave of psychedelic research being conducted in respectable institutions like NYU and Johns Hopkins. Along the way it touches on several monumental psychedelic events, including the coining of the term “psychedelic,” R. Gordon Wasson’s encounters with Maria Sabina, the CIA’s MKUltra experiments, Tim Leary’s impact on the scene, LSD leaking out of the lab and onto the streets, and the re-emergence of psychedelic research with Rick Strassman’s DMT study.

Several experts are featured in the film, including Charles Grob, Julie Holland, Rick Doblin, Katherine MacLean, Matthew Johnson, and Ingmar Gorman. Together, their interviews help paint a complete picture of psychedelics for the audience.

In addition to talking about the psychedelics themselves, the film also gives the viewer a chance to learn more about the people working in the psychedelic field, which often turns out to be both entertaining and enlightening. One good example is Charles Grob’s story about calling his father in the middle of the night to tell him he finally knew what he wanted to do for a career—he wanted to study psychedelics. His father was supportive of Charles’ decision but also cautioned that no one would take him seriously unless he got his credentials. So he did.

Psychedelia also features interviews with a handful of participants from a psilocybin for end-of-life anxiety study that was conducted at NYU. Their personal anecdotes about how psilocybin-assisted psychotherapy helped them are moving and inspirational, and if you’re anything like me then you might shed a tear or two while listening to their stories.

Several threads are sewed together to form a coherent film: a narrative detailing the history and science of psychedelics, explanations and insights from the experts, and the moving stories from the study participants. Like any good documentary, it has a beginning, a middle, and an end, and during the final credits an epilogue provides updates on what happened to some of the people in the film, which ties things up quite nicely.

After watching the whole thing, it’s crystal clear that Psychedelia was created by an adept filmmaker—someone who has obviously put in their 10,000 hours in order to learn the skills needed to create a masterpiece of this magnitude.

That man is Pat Murphy. He started working on the documentary in 2011, when he first heard about the psilocybin for end-of-life anxiety research study at NYU. At the time he was a student at NYU Tisch School of the Arts and so, coupled with an interest in the Grateful Dead (shoutout to all the fellow Deadheads out there!), Timothy Leary, and the 1960s, he decided to begin working on the film.

I liked Psychedelia quite a bit. For one thing, it features a ton of new footage that I hadn’t seen before—and I’ve seen a lot of movies about psychedelics.

Somehow Pat was able to make grainy old footage from way back in the day (for example: scenes from a 1955 CIA film) look fresh and new. And some of the audio recordings are a delight, featuring psychedelic elders like Albert Hofmann, Allen Ginsberg, and Ralph Metzner.

One of the funniest moments in the film (which will likely be overlooked by most viewers, as it is very subtle) occurs when Rick Doblin walks upstairs to a room with lots of paperwork strewn about on a desk where a big green bong is sitting upright, ready for a nice toke.

The documentary is so well-done that it comes across as incredibly professional, which goes a long way if you’re trying to convince a skeptic in your life about the value of psychedelics. In fact, I think this is the best film to introduce people to psychedelics that will give them solid overview of psychedelic history and science. It’s a perfect documentary to show your parents, your friends, or even your therapist if you’d like them to learn more about psychedelics without inundating them with too much information all at once. It’s nicely-paced, covering a lot of ground without rushing through. All in all, it’s a solid film.

Psychedelia is definitely worth a watch whether you are completely psychedelically-naïve or you’re a highly-experienced psychonaut, and while it’s not publicly available for streaming at the time that this blog post is going live, you can sign up for the film’s newsletter to find out how to attend a virtual screening event in the near future.

Pat is partnering up with psychedelic organizations and universities to hold these online events, which include Q&A sessions with the director after the film is screened. There are two events currently on the schedule—one on February 6th with the Psychedelic Society of Minnesota and another on February 11th with the Psychedelia Integration Community that will include Katherine MacLean on the Q&A panel. There’s also an option for universities and colleges to license the film for use in the classroom.

Regardless of when you are able to get a chance to watch Psychedelia, you should definitely put it on your radar and check it out as soon as you have the opportunity. It’s rare to find a documentary that encapsulates the history and science of psychedelics this well.

Disclaimer: I received a free screening copy of this film in exchange for an honest review. However, this is not a sponsored post—all thoughts and opinions expressed here are my own.

This Week in Psychedelics - 11.27.20

Cannabis

• Mexico’s Senate-Passed Marijuana Legalization Bill Moves To Chamber Of Deputies (Marijuana Moment)

• House Leadership Announces Vote On MORE Act To End Marijuana Prohibition Will Take Place Next Week (NORML)

• Marijuana Legalization Opponents Ask Courts To Overturn Voters’ Will In Several States (Marijuana Moment)

• Which States Are Poised to Advance Marijuana Legalization Reforms in 2021? (NORML)

• North Macedonia May Legalize Marijuana To Boost Tourism, Prime Minister Says (Marijuana Moment)

• New Jersey: Attorney General Issues Directive Halting Low-Level Marijuana Prosecutions (NORML)

• Republican Lawmakers And Celebrities Push Trump To Free Marijuana Prisoners Before Leaving Office (Marijuana Moment)

• Upcoming UN vote may be watershed moment for global medical cannabis – if only symbolic (Marijuana Business Daily)

• North Dakota: Gov. Burgum Issues Additional Pardons for Low-Level Marijuana Offenses (NORML)

• Connecticut Lawmakers Will Put Marijuana Legalization On The Ballot If Legislature Rejects Bill (Marijuana Moment)

• Federal Report: Marijuana Treatment Admissions Among Youth Decline Sharply in Legalization States (NORML)

• Number Of Banks Working With Marijuana Industry Continues To Drop Amid COVID, Federal Report Shows (Marijuana Moment)

LSD

• First Modern Dose-Response Study of LSD Confirms the Critical Role of the Serotonin 2A Receptor (Psychedelic Science Review)

• New doc 'My Psychedelic Love Story' remembers Timothy Leary (Fast Company)

Magic Mushrooms

• Psilocybin & migraine: First of its kind trial reports promising results (New Atlas)

• Two-Track Effort To Allow Psychedelic Mushrooms In Washington State Launches Amid Broader Drug Decrim Push (Marijuana Moment)

MDMA

• Research Suggests Past Antidepressant Usage Reduces Efficacy of MDMA-Assisted Psychotherapy for PTSD (Psilocybin Alpha)

• MDMA and Life Threatening Illnesses – A Commentary to Our Study (Psychedelic Support)

• Facilitating MDMA Therapy as a Treatment for PTSD with Marcela Ot’alora G (Chacruna)

Ayahuasca

• Two Arrested and Charged in Czech Republic for Distributing Ayahuasca (Lucid News)

• How Did Ayahuasca, Indigenous Diversity and Conservation Become Commodities in the Amazon? (Chacruna)

Ketamine

• Thailand's 'largest ketamine bust' turns out to be cleaning agent (BBC)

Datura

• Californian cave artists may have used hallucinogens, find reveals (Science Magazine)

Miscellaneous

• Vancouver Just Voted to Decriminalize All Drugs (VICE)

• Peter Thiel backs Berlin start-up making psychedelics in $125 million round (CNBC)

• What Removing the “Hallucinations” from Psychedelics Means for Psychotherapy (DoubleBlind)

• The world's first psychedelics hotline could help you work through a trip (Inverse)

• These Four Former Pro Athletes Are Using Psychedelics To Heal Their Brain Injuries (Forbes)

• Oregon County Prosecutor Stops Drug Possession Cases Early Following Decriminalization Vote (Marijuana Moment)

• BBC Two Programme to Follow Psychedelics vs. Antidepressants Trial (Psilocybin Alpha)

• University of Bristol hands free drug testing kits to students (BBC)

• Another Aspect of Reality: Maria Nys Huxley’s Influence on Psychedelic History (Chacruna)

• Middle East Science Diplomacy Focused on Psychedelics Could Generate Peace Dividends (Psychedelics Today)

• Catching Up With the Psychedelic Entourage Effect-Part 1: How We Got Here (Psychedelic Science Review)

• Psychedelics show religion isn’t the only route to spirituality (Psyche)

• Yu Maeda: A Psychedelic Artist Blending Japanese and American Influences (Sam Woolfe)

• Why California’s Future Psychedelics Legislation Should Start with Decriminalization of All Drugs (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.30.20

Cannabis

• New Zealand Marijuana Legalization Trails In Early Referendum Results, But More Votes To Be Counted (Marijuana Moment)

• New Jersey Lawmakers Approve Bill Providing Medical Marijuana Patient Insurance Benefits (Marijuana Moment)

• Study: Seniors Report Using Cannabis Products to Mitigate Symptoms Associated with Older Age (NORML)

• Mississippi Supreme Court Won’t Consider Challenge To Medical Marijuana Measure Until After Election (Marijuana Moment)

• South Dakota: Oglala Sioux Enacts Ordinance Legalizing Marijuana Use on Tribal Lands (NORML)

• New Jersey Marijuana Sales Could Start Just Weeks After Election Day Under Key Senator’s Plan (Marijuana Moment)

• Study suggests that cannabis can reduce OCD symptoms by half in short term (Hindustan Times)

• Idaho Activists Submit 2022 Medical Marijuana Initiative Following 2020 Complications (Marijuana Moment)

• Schools And NCAA Could Ban Marijuana Sponsorships Under Bill To Let Student Athletes Monetize Their Success (Marijuana Moment)

• Virginia NORML Calls for Legalization to Protect Marijuana Consumers from Potentially Tainted Products (NORML)

• South Dakota Voters Back Marijuana Legalization And Medical Cannabis Ballot Measures, Poll Finds (Marijuana Moment)

• The Music Never Stops With Jerry Garcia’s Just-Launched Cannabis Collection (Forbes)

LSD

• Killer High: Exploring the Phenomenon of LSD-Fuelled Murder (VICE)

• The psychedelics revolution has arrived in New Zealand (The Spinoff)

Magic Mushrooms

• Covid Can't Kill Mushrooms: The coronavirus has infected, but not killed, the movement to bring magic mushrooms to the masses (Rooster Magazine)

• Expanding On Psilocybin Research, John Hopkins Hoping To Hear From More Users (CBS Baltimore)

MDMA

• ‘Sorted’ for Es? Women and Ecstasy in 1990s Britain (Chacruna)

DMT

• SLU professor is authority on drug that landed him in jail (WWNY-TV)

Ayahuasca

• Ayahuasca Ceremonies and Tourism Return to Costa Rica (The Costa Rica Star)

• Studies lift the veil on psychedelic brew ayahuasca, its mental health benefits and potential to treat depression and trauma (South China Morning Post)

• Documentary looks at mystery medicine, Ayahuasca (The Leaf Online)

Mescaline

• What Is Mescaline? A Guide to this Cactus-Derived Psychedelic (DoubleBlind)

Synthetic Cannabinoids

• Synthetic cannabinoids linked to increased hospitalizations and deaths in older adults with COPD (Marijuana Business Daily)

• Synthetic Cannabis Could Disrupt The Marijuana Industry In A Big Way (Green Entrepreneur)

Ketamine

• Wearable Ketamine Delivery Device Developed As Alternative to Opioid-Based Pain Management (Lucid News)

• Ketamine Helps People Dislike Themselves Less (Psychedelic Science Review)

• Pharmather Files for FDA Orphan Drug Designation for Ketamine in Neuropathic Pain (Psilocybin Alpha)

• Can Dissociative Side Effect of “Floating” Predict Response to Ketamine in MDD? (Psychiatry Advisor)

Miscellaneous

• No Drugs Should Be Criminalized. It’s Time to Abolish the DEA. (Truthout)

• ‘Drug Free USA Forever’ Stamps Launched By DEA, Postal Service And Miss America (Marijuana Moment)

• Inside the ‘Psychedelic Exceptionalism’ Debate: Should All Drugs be Legal, or Just Pot and Psychedelics? (DoubleBlind)

• Psilocybin Group Therapy Improves Demoralization for AIDS Survivors (Chacruna)

• Children and Psychedelics: Re-examining Cultural Paradigms (Psychedelics Today)

• International study finds 79% of individuals who microdose with psychedelics report improvements in their mental health (PsyPost)

• Ketamine Meditation, Jungle Tripping and Modern-Day Shamans: Meet a ‘Psychedelic Concierge’ (VICE)

• The Role of Psychedelic Plant Medicines in Addiction Treatment (The Fix)

• A Collective Call for Accountability in Plant Medicine Experiences (Chacruna)

• Who owns psychedelics: patents and state therapeutic access laws (New Amsterdam Psychedelic Law)

• Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development (Psilocybin Alpha)

• What do Santo Daime and Raves Have in, Common? The Answer Might Move You (Chacruna)

• Journey Colab bags $3M from 'moonshot' fund to push new development model for psychedelic treatments (Fierce Biotech)

• Where Witchcraft Meets Plant Medicine (DoubleBlind)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.